Coronary artery aneurysm

Article written and reviewed by Dr Luca Moretti

A coronary artery aneurysm is a focal dilation of a segment of a coronary artery, conventionally defined by a diameter greater than 1.5 times that of an adjacent normal segment or the expected reference vessel. The definition is morphological and does not automatically identify the cause. A focal aneurysm must be distinguished from diffuse ectasia. Comparison may be difficult in uniform disease. Diameter, length, and measurement method must be reported.
The term includes true aneurysms, in which the arterial wall remains present although altered, and pseudoaneurysms, formed by a contained rupture that communicates with the lumen; this distinction is not semantic: it changes the risk of rupture, urgency, and exclusion strategy; a pseudoaneurysm often follows trauma, infection, or a procedure. Angiography shows only the opacified cavity. CCTA and intravascular imaging clarify its structure.

In adults, atherosclerosis is a frequent cause, but aneurysms may result from previous Kawasaki disease, vasculitides, congenital anomalies, connective tissue diseases, infection, dissection, or coronary intervention. In children, Kawasaki disease clearly predominates among acquired causes. Etiologic assessment is part of the diagnosis. The same morphology may have opposite biological behavior. Immunosuppression is appropriate only for documented inflammatory causes.
Most aneurysms are discovered incidentally during CCTA or coronary angiography, but dilation may produce stasis, mural thrombosis, distal embolization, ischemia, and infarction. Large lesions may compress nearby structures, form fistulas, or rupture; aneurysmal risk does not depend on diameter alone. Morphology, growth, thrombus, and associated stenoses are determinants. A small infected aneurysm may be more unstable than a large chronic one.

In adults, there is no universally accepted threshold for the term giant. The literature has used absolute values greater than 8, 20, or 40 mm and ratios exceeding four times the reference; these criteria are not interchangeable; the definition of giant must therefore be stated explicitly. In Kawasaki disease, the AHA classification instead uses Z scores and absolute diameter. Decisions must not be transferred automatically between adults and children.
Reported prevalences in angiographic series, generally ranging from fractions of a percentage point to a few percentage points, depend on the threshold adopted and the inclusion or exclusion of ectasia. Registries of patients undergoing coronary angiography do not represent the general population; the observed frequency reflects clinical selection and technology. CCTA identifies thrombus and external diameter not visible on luminography. Historical comparisons must therefore be interpreted cautiously.

Etiology, risk factors, pathogenesis, and pathophysiology

A true aneurysm forms when degradation of elastin and collagen, loss of smooth muscle cells, and remodeling exceed the wall's ability to withstand pressure. Dilation increases wall tension and further alters flow; expansive remodeling is not always equivalent to an aneurysm. In atherosclerosis it may accompany large eccentric plaques. The 1.5-fold threshold operationally separates the more pronounced phenotypes.
Atherosclerosis causes destruction and remodeling of the media through inflammation, proteases, oxidative stress, and matrix alterations, often in association with stenotic plaques within the same coronary tree. An atherosclerotic aneurysm is therefore part of diffuse disease, not simply an isolated dilation; the atherosclerotic burden influences prognosis and preventive therapy. Calcification and thrombus may make the lumen misleading. The external wall is measured more accurately with CCTA or IVUS.

In Kawasaki disease, early necrotizing arteritis damages the musculoelastic layers and may produce aneurysms within a few weeks. Subacute vasculitis and luminal myofibroblastic proliferation later contribute to thrombosis, stenosis, and late remodeling. A Kawasaki aneurysm retains risk beyond childhood. Apparent normalization of the lumen does not restore a normal wall. The maximum Z score remains essential in the clinical history.
Polyarteritis nodosa, Behçet disease, and other vasculitides may focally weaken a coronary artery through transmural necrosis or perivascular inflammation. Takayasu arteritis and IgG4-related disease more often cause proximal stenoses, but aneurysms have been described; active vasculitis may accelerate growth. Immunologic control does not eliminate preexisting anatomical damage. A multivisceral pattern supports the systemic diagnosis.

Congenital forms include dilations associated with anomalies of origin, coronary fistulas, and rare inherited wall fragilities. Connective tissue syndromes such as Marfan, Loeys-Dietz, and vascular Ehlers-Danlos have been reported, but coronary artery aneurysm is not their most common manifestation; genetic predisposition must be assessed in context. Aortic phenotype and family history are more informative. Indiscriminate genetic testing is not justified.
Infected aneurysms, historically termed mycotic even when bacterial, arise from endocarditis, bacteremia, stent infection, or contiguous spread. Rapid destruction of the wall may produce a fragile true aneurysm or a pseudoaneurysm; an infectious cause requires blood cultures and prompt imaging. Fever may be absent in immunocompromised patients. Immunosuppression without excluding infection may be catastrophic.

PCI, atherectomy, high-pressure balloon inflation, laser, perforation, and stent implantation may injure the media and adventitia. Delayed inflammatory reactions, malapposition, and stent infection are other reported mechanisms; an iatrogenic pseudoaneurysm may appear early or late. A relationship to the treated segment is a strong clue. Review of procedural images reconstructs the mechanism.
Within the dilated lumen, velocity decreases, vortices develop, and contact time between platelets and the altered wall increases. Stasis promotes mural thrombus, which may grow, organize, or embolize; the thrombogenic triad comprises abnormal flow, wall injury, and systemic state. The entire thrombus is not visible on luminography. Residual lumen diameter may underestimate the true size.

An increased radius raises the circumferential tension required to contain pressure, but Laplace's law cannot be applied as an isolated clinical predictor to a multilayered, pulsatile, irregular coronary wall. Thickness, shape, material, and external support modify risk; wall mechanics are more complex than diameter. A pseudoaneurysm with a narrow neck may rupture early. A large calcified cavity may remain stable for years.

Pathological anatomy, classification, and progression

The most useful operational distinction separates focal from diffuse dilation. An aneurysm involves a circumscribed segment, whereas ectasia extends over more than one third of the vessel length or, in some modern definitions, for more than 20 mm; the longitudinal criterion avoids terminological overlap. Historical studies have not always applied the same rule. Epidemiological comparison requires knowing the definition used.
A fusiform aneurysm dilates along the vessel axis and has a length greater than its transverse diameter; a saccular aneurysm forms a lateral cavity with a greater transverse diameter. The former often involves a more extensive portion of the wall, while the latter may have a narrow neck; saccular morphology sometimes facilitates coil embolization. Bifurcations and side branches complicate exclusion. Shape alone does not define etiology.

A true aneurysm contains altered intima, media, and adventitia; a pseudoaneurysm is bounded mainly by adventitia, pericardium, or fibrous tissue. A neck communicating with an extraluminal cavity supports the latter; wall continuity is assessed with CCTA, IVUS, or OCT. OCT has high resolution but limited penetration. IVUS better examines the entire wall and stent.
In Kawasaki disease, the AHA classifies coronary arteries by Z score: dilation from 2 to less than 2.5; small aneurysm from 2.5 to less than 5; medium aneurysm from 5 to less than 10 with an absolute diameter below 8 mm; large or giant aneurysm with a Z score of at least 10 or a diameter of 8 mm or greater; the pediatric classification normalizes for body surface area. A Z-score formula must be specified and used consistently. Isolated absolute measurements are inadequate in young children.

Definitions of giant aneurysm in adults are heterogeneous. Some series use a diameter exceeding four times the reference, others more than 20 mm, and some reports reserve the term for more than 40 mm; the adult cutoff is not standardized. Every report must state the actual measurement, not merely the adjective; the treatment decision integrates location and growth as well as size.
The right coronary artery is frequently involved in adult series, followed by the left anterior descending and circumflex arteries; the left main is less common but particularly critical. Proximal segments and bifurcations are typical in Kawasaki disease; the anatomical location determines the myocardium at risk and technical options. A left main aneurysm involves essential branches. A distal aneurysm may not permit effective bypass.

Progression includes stability, growth, luminal regression, thrombosis, calcification, and development of stenoses at the ends. In Kawasaki disease, small aneurysms frequently remodel, whereas giant aneurysms persist and develop late complications; angiographic regression may result from true remodeling or thrombus. The wall remains abnormal even after normalization. Follow-up depends on the maximum historical involvement.
A postprocedural aneurysm may expand, stabilize, or thrombose. Infection increases the risk of growth and rupture; antiplatelet therapy may mask partial filling without eliminating the wall defect; serial comparison must use similar planes and phases. An apparent change may result from different opacification. Confirmed growth requires urgent reassessment.

Complex aneurysms may contain communicating cavities, septa, thrombus of different ages, and residual channels. The irregular endoluminal surface modifies embolization risk and makes a single linear measurement unreliable; aneurysm volume may be more informative than diameter alone. However, no validated volumetric thresholds for intervention exist. Three-dimensional reconstruction is used primarily for technical planning.

Clinical manifestations

Many aneurysms cause no symptoms and are discovered during imaging for chest pain, Kawasaki disease follow-up, or assessment of other coronary disease. The finding does not establish that the symptom is caused by the dilation; an incidental finding requires complete characterization. Ischemia and anatomy must be correlated; a small stable cavity may not alter clinical management.
Chronic angina may result from an associated stenosis, organized thrombus, repeated embolization, or altered flow within the aneurysmal segment. The pain has no specific quality and is evaluated like any suspected ischemia; coronary flow reserve may be reduced without an evident focal obstruction. Stress imaging identifies the compromised territory. A negative test does not measure the risk of future thrombosis.

An acute coronary syndrome is the most important clinical presentation in adults. In situ thrombosis, distal embolization, concomitant atherothrombosis, or stent closure may produce STEMI or NSTEMI; an aneurysmal thrombus may be bulky and resistant. Reperfusion may cause embolization and no-reflow; the mechanism guides aspiration, anticoagulation, and the definitive strategy.
A child with Kawasaki disease may be completely asymptomatic despite important aneurysms. Years later, thrombosis or stenosis may present with pain, pallor, vomiting, irritability, syncope, or cardiac arrest, with manifestations varying by age; transition to adult care must preserve all documentation. An incomplete childhood history may obscure the cause. Proximal calcifications in young adults are a clue.

Very large aneurysms may compress the atrium, ventricle, pulmonary artery, vena cava, or other coronary branches. Dyspnea, congestion, ischemia, or filling abnormalities may result; extrinsic compression requires three-dimensional imaging. Severity does not necessarily correspond to pain; external dimensions, thrombus, and mediastinal relationships must be described.
A fistula to a cardiac chamber, coronary sinus, or pulmonary artery may produce a continuous murmur, volume overload, and coronary steal. Some fistulas are congenital and are associated with dilation of the feeding vessel; a fistulous communication completely changes the strategy. Doppler echocardiography and CCTA define flow and drainage. Dilation alone does not prove rupture.

Fever, bacteremia, persistent pain, or rapid expansion after PCI should raise suspicion of an infected aneurysm or pseudoaneurysm. The absence of systemic signs does not exclude infection in immunocompromised patients or after antibiotics; the infectious phenotype is a diagnostic emergency. Blood cultures precede antibiotics when clinically possible; percutaneous manipulation may disseminate infection.
Rupture and tamponade may present with sudden pain, hypotension, tachycardia, dyspnea, and loss of consciousness, but symptoms may be attenuated if leakage is temporarily contained. An acquired fistula may instead produce progressive dyspnea and a murmur; hemodynamic deterioration mandates bedside echocardiography. CCTA is performed only in a stable patient. Cardiac surgery must be involved without avoidable delay.

Investigations and diagnosis

The diagnosis must answer five questions: is the dilation focal or diffuse, a true aneurysm or pseudoaneurysm, stable or growing, thrombosed or patent, isolated or associated with stenoses and branches? Age and clinical history guide the etiology; systematic characterization precedes any treatment. Measurements must be obtained perpendicular to the axis. The reference must be selected while avoiding diffusely diseased segments.
In children with Kawasaki disease, serial echocardiography is the initial modality. Internal measurements of the right coronary and left anterior descending arteries are converted to Z scores and integrated with ventricular function and assessment of the pericardium, valves, and aortic root. Pediatric echocardiography avoids radiation and sedation. Quality depends on the acoustic window and experience. Distal segments or complex aneurysms require CCTA or MRI.

CCTA is particularly suited to defining external diameter, length, shape, neck, mural thrombus, calcification, stenosis, and relationship to adjacent structures. Multiplanar reconstructions avoid overestimation from oblique projection; coronary CCTA distinguishes the opacified cavity from the external wall. A high heart rate and calcium may reduce accuracy. The protocol must minimize dose, especially in young patients.
Invasive coronary angiography retains a role in acute syndromes and when a procedure is planned. It provides excellent dynamic visualization of the lumen, collaterals, flow, and branches, but thrombus may make a markedly expanded wall appear normal or only moderately dilated; invasive luminography underestimates extraluminal extent. Forceful injections require caution in pseudoaneurysms. Multiple projections clarify the neck and bifurcations.

IVUS visualizes the external elastic membrane, wall layers, plaque, thrombus, and relationship to a stent, making it useful for distinguishing a true aneurysm, pseudoaneurysm, and malapposition. OCT resolves the surface, communication, and stent details better but penetrates thrombus and large cavities less effectively. Intravascular imaging is selected according to the question. It must not unnecessarily increase the risk of perforation. An infected cavity is not instrumented without an agreed strategy.
Cardiac magnetic resonance imaging assesses function, perfusion, and scar without radiation and may depict proximal coronary segments with dedicated sequences. It has lower resolution than CCTA for small branches but is valuable for repeated follow-up in selected young patients. Late enhancement identifies previous infarctions. Stress perfusion documents inducible ischemia. Clips, stents, and arrhythmias may limit quality and interpretation.

Stress echocardiography, PET, SPECT, or MRI determines whether stenoses, thrombus, or altered flow produce ischemia. The test is selected according to age, ECG, function, and availability; high-risk anatomy may require treatment regardless of the test; functional assessment does not measure wall fragility. A negative result does not exclude rupture or future thrombosis. It is used mainly to plan revascularization and follow-up.

Minimum description of a coronary artery aneurysm

• Vessel, segment, maximum diameter, length, and ratio to an explicitly defined reference.
• Fusiform or saccular morphology and classification as a true aneurysm or pseudoaneurysm when determinable.
• Presence, extent, and organization of mural thrombus, calcification, and stenosis at the inlet or outlet.
• Involvement of bifurcations, side branches, stents, fistulas, and adjacent cardiac or mediastinal structures.
• Comparison with previous examinations using reproducible measurements and indication of the possible etiology.

The differential diagnosis includes ectasia, positive atherosclerotic remodeling, fistula, diverticulum, an opacified cardiac chamber, a dilated vein graft, and a sinus of Valsalva pseudoaneurysm. An adjacent stenotic segment may make a normal segment appear falsely aneurysmal; a pathological reference distorts the dimensional ratio. Three-dimensional review reduces projection errors. Etiology is confirmed with systemic and procedural data.
When previous Kawasaki disease is suspected, reconstruction includes any pediatric hospitalizations, echocardiograms, immunoglobulin therapy, and maximum Z score. A young adult with proximal calcifications and stenoses at the ends of a dilation merits expert assessment; clinical memory may be incomplete after decades. The absence of a childhood diagnosis does not exclude an unrecognized form. The morphology remains suggestive, not pathognomonic.

When a post-PCI pseudoaneurysm is suspected, the position of the balloon, stent, and perforation must immediately be compared with current images. Blood cultures and infectious markers are added when fever, a recent implant, or perivascular signs are present; procedural reconstruction may identify the entry point. A malapposed stent changes the coverage strategy. The original procedure must not be interpreted solely from the written report.

Treatment and prognosis

There are insufficient randomized trials to impose a single strategy for coronary artery aneurysms in adults. The decision integrates symptoms, ischemia, cause, diameter, growth, shape, thrombus, stenoses, bifurcations, and procedural risk; individualized treatment is required by the evidence. A stable aneurysm does not automatically require exclusion. A small but infected or pseudoaneurysmal lesion may require urgent treatment.
The cause is treated directly: intensive atherosclerotic prevention for atherosclerotic forms, immunotherapy for active vasculitides, antibiotics and source control for infections, and device revision for iatrogenic complications; etiologic treatment reduces new damage but does not always correct the cavity. Blood pressure, smoking, lipids, and diabetes are controlled. A statin is not prescribed for diameter alone in the absence of a cardiovascular indication.

Single antiplatelet therapy is frequently used in adults with atherosclerosis or previous PCI, but there is no evidence that it should be universal for every isolated congenital aneurysm. Dual antiplatelet therapy primarily follows an acute coronary syndrome or stenting; the antiplatelet strategy derives from the ischemic context. Bleeding risk must be quantified. A stable cavity without plaque is not equivalent to secondary prevention.
Anticoagulation is considered when a very large aneurysm, thrombus, marked stasis, embolic events, or high-risk Kawasaki disease is present, but adult data are observational and susceptible to confounding. Warfarin and direct anticoagulants are not interchangeable in every scenario. Selective anticoagulation requires assessment of bleeding risk. Combination with antiplatelet agents increases bleeding. Follow-up verifies thrombus, adherence, and the continuing indication.

In Kawasaki disease, the 2024 AHA strategy is graded according to maximum Z score and current diameter. Persistent small aneurysms receive low-dose aspirin; adding clopidogrel may be considered for medium aneurysms; anticoagulation combined with aspirin is indicated for persistent large or giant aneurysms; AHA stratification includes follow-up and stress imaging. DOACs may be considered in selected settings. Transition from pediatric care must be planned.
Acute thrombosis requires reperfusion according to presentation, but large thrombus burdens increase embolization and no-reflow. Anticoagulation, platelet inhibitors, selective thrombectomy, and intracoronary thrombolysis have been used without a universal specific algorithm; the thrombus burden guides the catheterization strategy. Intravascular imaging avoids unnecessarily undersized stents. Definitive treatment of the cavity may be deferred until after stabilization.

A covered stent may exclude saccular aneurysms or pseudoaneurysms in relatively straight segments with adequate landing zones and no essential branches. Bulky profiles, thrombosis, restenosis, and side-branch occlusion limit its use; a covered stent is not suitable for every anatomy. Incorrect sizing promotes malapposition. DAPT and surveillance follow the device and clinical risk.
Embolization with coils, plugs, or assisted techniques may close aneurysms with a favorable neck, particularly distal aneurysms or those on expendable branches, sometimes protecting the main vessel with a stent. Risks include migration, perforation, and territorial ischemia. Selective embolization requires three-dimensional planning. Distal flow must be preserved or judged expendable. An associated fistula changes the target and material.

Surgery includes aneurysm ligation or resection, closure of communications, and bypass to the distal bed. It is favored for giant lesions, growth, compression, fistula, rupture, infection, left main involvement, or anatomy unsuitable for PCI; surgical bypass depends on a good distal vessel. Thrombus and adhesions increase complexity. A Heart Team discussion compares operative risk and durability.
Surveillance is individualized. CCTA defines anatomical changes, while stress imaging and clinical assessment look for ischemia; cumulative exposure to radiation and contrast is limited in young patients; serial follow-up uses the same metric whenever possible. Frequency increases with growth, thrombus, or symptoms; an aneurysm stable for years may be monitored less often.

The choice among observation, PCI, and surgery must also consider the potential loss of side branches. Excluding a cavity may sacrifice a branch supplying viable myocardium, while leaving it patent may maintain thrombotic risk; the branch map is therefore part of collegial Heart Team assessment. FFR or stress imaging may clarify the territory. Patient preference is discussed together with uncertainty and alternatives.
For patients without an immediate indication for intervention, the plan must specify the imaging interval, symptoms requiring urgent assessment, and the objective of antithrombotic therapy. A prescription without a duration or reassessment criterion tends to persist even when the benefit-risk ratio changes; scheduled reassessment improves safety and adherence. New anemia or bleeding changes the strategy. New thrombus or growth instead changes ischemic risk.

Prognosis is heterogeneous, and registries combine different causes and definitions. Events are more frequent when obstructive coronary disease, thrombus, a large diameter, previous events, or reduced ventricular function coexist; overall risk is more informative than a single measurement. Small regressed Kawasaki aneurysms often have a favorable course. Giant forms require lifelong surveillance and thromboprophylaxis.
Before a noncardiac procedure, clinicians determine whether antithrombotic therapy can be interrupted, continued, or temporarily replaced. Risk depends on recent thrombus, stenting, previous infarction, and aneurysm size, not merely the lesion's name; perioperative management requires a written plan. Bridging is not automatically useful for every anticoagulant. Surgical urgency and bleeding risk are discussed with the specialists involved.

Complications

Mural thrombosis is the most characteristic complication. It may progressively narrow the lumen, organize within the wall, or destabilize, producing acute occlusion and infarction; aneurysmal stasis promotes thrombi even without severe stenosis. CCTA visualizes nonopacified components; a rapid change in the lumen may reflect thrombus rather than external remodeling.
Fragments of thrombus may embolize into distal branches, causing multiple infarctions, slow flow, and microvascular obstruction. During PCI, wires, balloons, and contrast may mobilize material and worsen perfusion; distal microembolization explains no-reflow despite epicardial patency. Embolic protection is not always technically possible. Final damage is quantified with biomarkers and imaging.

Rupture may produce hemopericardium and tamponade, mediastinal hemorrhage, or a fistula into a nearby chamber or vessel. It is rare in chronic aneurysms but more concerning in pseudoaneurysms, infections, and rapid growth; a contained rupture may precede hemodynamic collapse. A new effusion and pain require urgent assessment; pericardiocentesis may be only a bridging measure.
A very large cavity may compress the pulmonary artery, cardiac chambers, veins, bronchi, or coronary branches. Compression may cause ischemia, right-sided congestion, dyspnea, or recurrent respiratory infections; an aneurysmal mass often includes substantial thrombus. Luminal diameter underestimates its bulk. CCTA or MRI is essential to plan decompression and bypass.

Fistulas may cause a shunt, volume overload, progressive dilation of the feeding vessel, and coronary steal. An acquired fistula may result from erosion of the aneurysm into an adjacent structure; coronary steal depends on resistance and flow. Not every fistula requires immediate closure; symptoms, dilation, and shunt ratio guide the decision.
Infarction and chronic ischemia may produce scar, ventricular dysfunction, mitral regurgitation, arrhythmias, and heart failure. In young children, an infarction may occur without the classic description of pain; post-ischemic damage influences prognosis in addition to the aneurysm. Magnetic resonance imaging defines viability and scar; heart failure therapy and arrhythmic prevention follow general principles.

Procedural complications include perforation, coil embolization, branch occlusion, thrombosis or restenosis of a covered stent, and graft failure. Incomplete exclusion may leave an endoleak and continued cavity growth; procedural patency requires follow-up imaging. Antithrombotic therapy must protect the device without excessive bleeding. An immediate angiographic result does not guarantee durability.
Anxiety, unjustified physical restriction, and loss to follow-up may impair quality of life, particularly among Kawasaki disease survivors transitioning to adult services. Education must distinguish permitted activities, warning symptoms, and the need for adherence; continuity of care prevents interruptions in anticoagulation. Contact sports require assessment during antithrombotic therapy. Pregnancy must be planned in high-risk phenotypes.

Pregnancy in the presence of a giant aneurysm or anticoagulation requires planning before conception. The antithrombotic regimen changes in relation to trimester, delivery, and breastfeeding, while increased cardiac output may alter symptoms; obstetric management is coordinated at an expert center. Warfarin and direct anticoagulants have specific limitations. Unsupervised discontinuation places both mother and fetus at risk.